Md. firm’s treatment earns FDA clearance for Covid patients with drug-resistant infections
November 18, 2020 at 11:42 AM EST
The Maryland biotech's virus-based therapy targets superbugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|